β-blocker dosage and outcomes after acute coronary syndrome

Conclusions In ACS patients, rates of MACE for high-dose and low-dose β-blocker doses are similar. These findings question the importance of achieving a high dose of β-blocker in ACS patients and highlight the need for further investigation of this clinical question.
Source: American Heart Journal - Category: Cardiology Source Type: research